Empowered Funds’s Usana Health Sciences USNA Stock Holding History

Empowered Funds’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.5M	Buy	70,253 +3,960	+6%	+$74.4K	0.01%	1327
2026 Q1	$1.16M	Buy	66,293 +5,856	+10%	+$116K	0.01%	1354
2025 Q4	$1.19M	Buy	60,437 +5,782	+11%	+$120K	0.02%	617
2025 Q3	$1.51M	Buy	54,655 +26,788	+96%	+$824K	0.02%	1035
2025 Q2	$851K	Buy	27,867 +2,384	+9%	+$67.7K	0.01%	1137
2025 Q1	$687K	Buy	+25,483	New	+$807K	0.01%	1116
2020 Q4	–	Sell	-36,990	Closed	-$2.72M	–	220
2020 Q3	$2.72M	Buy	36,990 +4,698	+15%	+$377K	0.85%	48
2020 Q2	$2.37M	Buy	+32,292	New	+$2.53M	0.92%	48

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's USNA Position: Q2 2026 in Review

Empowered Funds increased its Usana Health Sciences (USNA) stake by 6% in Q2 2026, buying an estimated $74.4K and bringing the position to 70,253 shares worth $1.5M. The position accounts for 0.01% of the portfolio, ranked #1327.

Empowered Funds first reported a position in USNA in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.72M in Q3 2020. 138 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Empowered Funds held 70,253 shares of Usana Health Sciences worth $1.5M as of Q2 2026.
Empowered Funds bought 3,960 Usana Health Sciences shares in Q2 2026, an estimated $74.4K.
Usana Health Sciences made up 0.01% of Empowered Funds's portfolio in Q2 2026, its #1327 holding.
Empowered Funds first reported a position in Usana Health Sciences in Q2 2020 and has held it in 8 quarters since.
Empowered Funds's Usana Health Sciences position peaked at $2.72M in Q3 2020.
138 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.